Obeticholic acid, a farnesoid X receptor agonist, improves portal hypertension by two distinct pathways in cirrhotic ratsLen Verbeke(AZ Sint-Lucas), Wim Laleman(University Hospital Münster)HepatologyNovember 20, 201310.1002/hep.26939Cited by 257SaveCiteExport RISWatch citationsRelated PapersEffect of the molecular adsorbent recirculating system and Prometheus devices on systemic haemodynamics and vasoactive agents in patients with acute-on-chronic alcoholic liver failure|Critical Care|2006|249Spleen stiffness measurement by vibration-controlled transient elastography at 100 Hz for non-invasive predicted diagnosis of clinically significant portal hypertension in patients with compensated advanced chronic liver disease: a modelling study|The Lancet. Gastroenterology & hepatology|2024|69